Corrigendum to "Interaction of phenylbutazone and colchicine in binding to serum albumin in rheumatoid therapy: 1H NMR study" [Spectrochim. Acta Part A 74 (2009) 1-9] (DOI:10.1016/j.saa.2009.06.043);Interaction of phenylbutazone and colchicine in binding to serum albumin in rheumatoid therapy: 1H NMR study

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy

Volumn 74, Issue 1, 2009, Pages 1-9

  Maciazek Jurczyk, M ^a   Sulkowska A ^a   Bojko, B ^a   Rownicka Zubik J ^a   Sulkowski W W ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b UNIVERSITY OF SILESIA   (Poland)

Author keywords

Colchicine; Competition; Interaction with serum albumin; Phenylbutazone

Indexed keywords

BINDING SITES; BODY FLUIDS; COMPETITION; DISEASE CONTROL; DRUG THERAPY; NUCLEAR MAGNETIC RESONANCE; SPECTROSCOPIC ANALYSIS;

AFFINITY BINDING; COLCHICINE; COMBINATION THERAPY; DRUG CONCENTRATION; PHENYLBUTAZONE; PROTON NUCLEAR MAGNETIC RESONANCE; SERUM ALBUMIN; SPECTROSCOPIC STUDIES;

DRUG INTERACTIONS;

ANTIINFLAMMATORY AGENT; COLCHICINE; DIAGNOSTIC AGENT; PHENYLBUTAZONE; PROTON; SERUM ALBUMIN;

BIOLOGICAL MODEL; BLOOD; DRUG COMBINATION; DRUG EFFECT; DRUG INTERACTION; HUMAN; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BINDING; REVIEW; RHEUMATIC DISEASE;

ANTI-INFLAMMATORY AGENTS; COLCHICINE; DRUG COMBINATIONS; DRUG INTERACTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; PHENYLBUTAZONE; PROTEIN BINDING; PROTONS; RHEUMATIC DISEASES; SERUM ALBUMIN;

EID: 68849122761     PISSN: 13861425     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.saa.2010.01.005     Document Type: Erratum

References (26)

1. Sułkowska A., et al. J. Mol. Struct. 881 (2008) 97-106
2. Sudlow G., Birkett D.J., and Wade D.N. Mol. Pharmacol. 11 (1975) 824-832
3. Kragh-Hansen U. Pharmacol. Rev. 33 (1981) 17-53
4. Carter D.C., and Ho J.X. Adv. Protein Chem. 45 (1994) 153-203
5. Russeva V., and Mihailova D. Arzneimittel-Forsch 49 (1999) 255-258
6. Peters Jr. T. All About Albumin: Biochemistry, Genetics and Medical Applications (1996), Academic Press, New York
7. Kragh-Hansen U., Chuang V.T., and Otagiri M. Biol. Pharm. Bull. 25 (2002) 695-704
8. Bhattacharya A.A., Curry S., and Franks N.P. J. Biol. Chem. 275 (2000) 38731-38738
9. Dockal M., Chang M., Carter D.C., and Ruker F. Protein Sci. 9 (2000) 1455-1465
10. Petitpas I., Bhattacharya A.A., Twine S., East M., and Curry S. J. Biol. Chem. 276 (2001) 22804-22809
11. Huang B.X., Dass C., and Kim H.-Y. J. Am. Soc. Mass Spectrom. 15 (2004) 1237-1247
12. Berger R.G. J. Am. Acad. Orthop. Surg. 2 (1994) 255-260
13. Zhu-Sheng J., et al. Chem. Pharm. Bull. 50 (2002) 1017-1021
14. Maes V., Hoebeke J., Vercruysse A., and Kanarek L. Mol. Pharmacol. 16 (1979) 147-153
15. Oravcovà J., Böhs B., and Lindner W. J. Chromatogr. B 677 (1996) 1-28
16. Bakhmutov V.I. Practical NMR Relaxation for Chemists (2004), John Wiley & Sons Ltd., England
17. Sułkowska A., Bojko B., Równicka J., and Sułkowski W.W. Biopolymers 74 (2004) 256-262
18. Sułkowska A., Bojko B., Równicka J., and Sułkowski W.W. Biopolymers 81 (2006) 464-472
19. Sułkowska A., Bojko B., Równicka J., Rezner P., and Sułkowski W.W. J. Mol. Struct. 744-747 (2005) 781-787
20. Hu Y.J., Liu Y., Zhao R.M., and Qu S.S. Int. J. Biol. Macromol. 37 (2005) 122-126
21. Luo R.S., Liu M.L., and Mao X.A. Spectrochim. Acta A. Mol. Biomol. Spectrosc. A 55 (1999) 1897-1901
22. Oida T. J. Biochem. 100 (1986) 99-113
23. Tanaka M., Asahi Y., Masuda S., and Ota T. Chem. Pharm. Bull. 37 (1989) 3177-3180
24. Sułkowska A., Macia{ogonek}żek-Jurczyk M., Bojko B., Równicka J., and Sułkowski W.W. J. Mol. Struct. 891 (2008) 278-283
25. Honma K., Nakamura M., and Ishikawa Y. Mol. Immunol. 28 (1991) 107-113
26. Abragam A. Principles of Nuclear Magnetism (1985), Oxford at the Clarendon Press, New York